We are live on ! Find out more
NA

Nordwand Advisors Portfolio holdings

AUM $572M
1-Year Est. Return 23.09%
This Fund
S&P 500
This Quarter Est. Return
+8.55%
1 Year Est. Return
+23.09%
3 Year Est. Return
+66.91%
5 Year Est. Return
10 Year Est. Return
AUM
$374M
AUM Growth
+$144M
Cap. Flow
+$127M
Cap. Flow %
34.03%
Top 10 Hldgs %
96.9%
Holding
174
New
23
Increased
5
Reduced
15
Closed
33

Sector Composition

Rank Sector Weight
1 Healthcare 45.87%
2 Financials 43.41%
3 Technology 4.41%
4 Consumer Discretionary 0.88%
5 Materials 0.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UL icon
101
Unilever
UL
$137B
$6.24K ﹤0.01%
85
-2,585
-97% -$179K
DOCU
102
DocuSign
DOCU
$10.5B
$6.21K ﹤0.01%
100
FEMY icon
103
Femasys
FEMY
$8.97M
$5.55K ﹤0.01%
250
GBIL icon
104
Goldman Sachs Access Treasury 0-1 Year ETF
GBIL
$7.57B
$4.51K ﹤0.01%
45
XLP icon
105
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.8B
$4.15K ﹤0.01%
50
GROV icon
106
Grove Collaborative
GROV
$45.8M
$4.05K ﹤0.01%
+3,000
New +$4.28K
BIL icon
107
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$46.9B
$3.58K ﹤0.01%
39
MURA
108
DELISTED
Mural Oncology
MURA
$3.13K ﹤0.01%
+1,000
New +$3.26K
RETO icon
109
ReTo Eco-Solutions
RETO
$24.6M
$3.02K ﹤0.01%
+10
New +$2.76K
PMVP icon
110
PMV Pharmaceuticals
PMVP
$59.7M
$2.98K ﹤0.01%
2,000
AIFU
111
AIFU Inc
AIFU
$213M
$2.84K ﹤0.01%
+5
New +$2.8K
MRSN
112
DELISTED
Mersana Therapeutics
MRSN
$2.83K ﹤0.01%
60
CRNT icon
113
Ceragon Networks
CRNT
$200M
$2.74K ﹤0.01%
1,000
AGG icon
114
iShares Core US Aggregate Bond ETF
AGG
$137B
$2.73K ﹤0.01%
27
-866
-97% -$86.4K
VOO icon
115
Vanguard S&P 500 ETF
VOO
$993B
$2.64K ﹤0.01%
5
ORMP icon
116
Oramed Pharmaceuticals
ORMP
$180M
$2.44K ﹤0.01%
+1,000
New +$2.44K
XPEV icon
117
XPeng
XPEV
$11.8B
$2.44K ﹤0.01%
200
FTSM icon
118
First Trust Enhanced Short Maturity ETF
FTSM
$6.5B
$2.4K ﹤0.01%
40
ARKK icon
119
ARK Innovation ETF
ARKK
$5.84B
$2.38K ﹤0.01%
50
AMPX icon
120
Amprius Technologies
AMPX
$1.43B
$2.22K ﹤0.01%
2,000
USIO icon
121
Usio Inc
USIO
$61.3M
$2.04K ﹤0.01%
+1,500
New +$2.25K
TFFP
122
DELISTED
TFF Pharmaceuticals, Inc. Common Stock
TFFP
$2.01K ﹤0.01%
+1,000
New +$1.97K
OCEA
123
DELISTED
Ocean Biomedical, Inc. Common Stock
OCEA
$1.96K ﹤0.01%
+2,000
New +$2.14K
QSI icon
124
Quantum-Si Incorporated
QSI
$162M
$1.76K ﹤0.01%
+2,000
New +$1.94K
PASG icon
125
Passage Bio
PASG
$14.4M
$1.75K ﹤0.01%
+125
New +$1.99K

Similar funds

Nordwand Advisors's Q3 2024 Portfolio in Review

As of Q3 2024, Nordwand Advisors held 174 positions worth $374M, up 63% from $229M the previous quarter. Its ten largest holdings account for 97% of the portfolio.

Nordwand Advisors deployed $127M of net new capital in Q3 2024, opening 23 new positions and adding to 5 existing holdings. Its largest new stake was Harbor International Compounders ETF: 149,085 shares worth $4.31M.

By sector, the portfolio is most concentrated in Healthcare at 46% of assets, up from 33% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was JPMorgan Income ETF, an estimated $3.02M trimmed.

  • Nordwand Advisors's largest Q3 2024 buy was Harbor International Compounders ETF: 149,085 shares worth $4.31M.
  • Nordwand Advisors added most to Johnson & Johnson in Q3 2024, an estimated $68.7M increase.
  • Nordwand Advisors's biggest Q3 2024 reduction was JPMorgan Income ETF, cutting an estimated $3.02M.
  • Nordwand Advisors fully exited TSMC in Q3 2024, selling an estimated $397K.
  • Nordwand Advisors's ten largest holdings make up 97% of its $374M portfolio in Q3 2024.
  • Nordwand Advisors opened 23 new positions and closed 33 in Q3 2024.
  • Nordwand Advisors's portfolio value rose 63% quarter-over-quarter to $374M.

Based on Nordwand Advisors's 13F filing for Q3 2024, filed 1 Nov 2024.